Phase4 Partners

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2015	Nabriva Therapeutics	$120.0M Series B	OrbiMed, Chen Yu	Novartis Venture Fund, Omega Funds, Boxer Capital, EcoR1 Capital, Global Life Science Ventures, HBM-MedFocus, Novartis

Total Raised

N/A

Valuation

N/A